Trade SUPN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Supernus Pharmaceuticals, Inc. (SUPN) is trading at US$41.64, down 0.12% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$2.67B. Over the past 52 weeks, SUPN has traded between US$41.11 and US$59.68. On Syfe you can trade SUPN with $0 commission and add it to your watchlist.
| Previous close | US$41.69 |
|---|---|
| Market cap | US$2.67B |
| P/E ratio | 10.69 |
| 52-week range | US$41.11 – US$59.68 |
| Volume | 707.16K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.
Year: 2012
Sector Update: Healthcare Stocks Rise Pre-Bell Monday
Aug 3, 1:15 PM · MT Newswires
Supernus Pharmaceuticals, Indivior Pharmaceuticals to Merge in All-Stock Deal
Aug 3, 11:15 AM · MT Newswires
Supernus Pharmaceuticals Swings to Q2 Net Loss, Revenue Rises; Fiscal 2026 Revenue Outlook Raised
Aug 3, 11:11 AM · MT Newswires
--Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger
Aug 3, 10:52 AM · MT Newswires
--Earnings Flash (SUPN) Supernus Pharmaceuticals Posts Q2 Net Loss $1.01 a Share, vs. FactSet Est of $0.04 EPS
Aug 3, 10:38 AM · MT Newswires
Supernus Pharmaceuticals, Inc. (SUPN) stock is trading at US$41.64, -0.12% from the previous close of US$41.69.
The market cap for Supernus Pharmaceuticals, Inc. (SUPN) stock is approximately US$2.67B.
The price-to-earnings ratio for Supernus Pharmaceuticals, Inc. (SUPN) is 10.69, based on the latest reported earnings.
The 52-week high for Supernus Pharmaceuticals, Inc. (SUPN) stock is US$59.68.
The 52-week low for Supernus Pharmaceuticals, Inc. (SUPN) stock is US$41.11.
Supernus Pharmaceuticals, Inc. (SUPN) does not currently pay a dividend.
Stay on top of SUPN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
